Tests a probiotic supplement on fat and hormones in women with obesity
Tests a probiotic supplement against a placebo in women with obesity.
Plain-language title generated from the registry record
Registry title: Lactobacillus Plantarum and Hormonal Regulation in Obese Women
Key facts
- Where
- Zhengzhou, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
Source: NCT06987279, who can take part
Where in China
- Fuwai Central China Cardiovascular HospitalZhengzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Wecare Probiotics Co., Ltd.
- Trial code
- NCT06987279
- Record updated
- 23 May 2025
- Original description
To evaluate the regulatory effect of Lactobacillus plantans Lp90 formula on visceral fat metabolism and sex hormone balance in obese women.Read full original descriptionShow less
Lactobacillus Plantarum Lp90 and Hormonal Regulation in Obese Women：A Randomized, Double-Blind, Placebo-Controlled Trial
To evaluate the regulatory effect of Lactobacillus plantans Lp90 formula on visceral fat metabolism and sex hormone balance in obese women.
Inclusion: Age: 18 to 40 years old, female, BMI ≥ 25 kg/m2; Be willing to receive follow-up during the intervention period; Be willing to provide two blood, urine and fecal samples during the intervention period; Be willing to take the compound probiotics by oneself every day during the intervention period; Have good hearing and be able to hear and understand all instructions during the intervention period; -.
Exclusion: Have received/are currently receiving treatment for the following mental illnesses: alcohol/drug/substance abuse dependence, schizophrenia, psychosis, bipolar disorder; Take medication for depression or low mood; Have received radiotherapy or chemotherapy in the past; Have received general anesthesia surgery/procedures within the past three years, or plan to receive general anesthesia procedures/surgeries within the next three months during this trial; Suffering from digestive system diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease); Suffering from severe neurological disorders (epilepsy, stroke, severe head trauma, meningitis within the past 10 years, brain surgery, brain tumor, long-term coma - excluding general anesthesia); Suffering from internal organ failure (such as heart, liver or kidney failure, etc.); Have suffered from hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past; -.